Trust round-up: Bankers, AVI Japan, Aquila European, Partners Group Private Equity

We summarise the latest news from four investment companies, from results to buybacks.

Bankers (BNKR)

Performance

The £1.5bn Janus Henderson-run global equity trust reported a net asset value (NAV) total return of 18.1% in the year to end of October, and a 22.8% increase in its share price. The latter just pipped the FTSE World index’s 21% return to the post, but the NAV slipped behind despite a portfolio reorganisation to increase the beta and reduce the number of holdings to 100.

The trust announced its 59th consecutive annual dividend increase with a total payout of 2.744p being 2.1% above last year’s distribution. However, the board had to dip into reserves to cover the dividend growth as revenue earnings per share came in at 2.3p over the year resulting in dividend cover of 0.84 times.

All change

The year was one of change for Bankers, with the investment team strengthened by the appointment of Richard Clode as co-fund manager alongside long-standing manager Alex Crooke.

The strategy was also re-jigged to focus on the highest conviction positions. It lowered exposure to defensive, lower growing sectors such as healthcare, real estate and consumer staples, while topping up on technology companies. Its US allocation was also increased from 50% at the start of the year to 65% by the end of 2026.

Runners and riders

While its heightened US exposure saw the trust stumble at the beginning of the reporting year, it soon picked up. Returns were most driven by the likes of Broadcom, Alphabet, and Microsoft.

‘These and the other major US tech companies continued to produce results that exceeded market forecasts and are deploying the cash they generate to support future investments in artificial intelligence (AI) infrastructure,’ said the managers.

Although the US dominated returns, the managers said stocks with US exposure derated on tariff concerns they would lose out to US competitors.

‘Performance has been better in recent months and into the new year, as investors are less concerned with the impact of tariffs on global trade,’ they said.

Outlook

Crooke and Clode said returns have been broadening out and they predicted economic activity would pick up as uncertainty around US trade eases, encouraging businesses to spend again.

‘The recovery in consumer-related sectors will take longer as new job creation has been impacted by higher taxes in many parts of the world,’ they said.

‘Our largest sector exposures relative to the benchmark are technology, financials and industrials, all areas we expect to perform well in the coming year.’

 

AVI Japan Opportunity (AJOT)

Tender offer

The £473m portfolio of Japanese smaller companies announced plans for a tender offer in December. It received applications from shareholders to tender 26.8m shares, equivalent to 10.9% of the issued share capital.

It will purchase the shares at a 2% discount to the net asset value (NAV) per share at the calculation date minus any transaction costs associated with selling assets to return cash to investors.

Monthly update

In a monthly factsheet, the fund confirmed a 1.9% increase in NAV in December, beating the 1.1% return from the MSCI Japan Small Cap benchmark.

Manager Joe Bauernfreund said the biggest contributors to performance were Synchro Food, which approved the appointment of Asset Value Investors (AVI) head of Japan research Kaz Sakai to the board as an independent director.

Broadmedia was also a winner and a stock which AVI said it will acquire an extra 11% of shares via a tender offer.

Merger ongoing

Bauernfreund said the AJOT team continues to allocate capital following the completion of the merger with Fidelity Japan in late November.

‘As of year-end, well over half of the capital received has been deployed,’ he said.

‘Meanwhile, the weights of exchange traded funds (ETFs) received to provide temporary market exposure continue to reduce, accounting for 14% of NAV at year-end.’

Bauernfreund said he was ‘excited by the opportunity to utilise addition firepower following the merger…to enhance our constructive engagement strategy with portfolio companies’.

 

Aquila European Renewables (AERI)

Distribution

The £420m renewable energy infrastructure trust is making its first distribution under its B share scheme as part of its wind-down. This will allow it to issue special, temporary B shares to existing shareholders which are immediately redeemed for cash, providing a tax-efficient way to return cash.

Asset sales

AERI completed the sale of its 18% stake in Portuguese hydropower asset Sagres in June 2025 for €14.7m (£12.7m) and the disposal of Danish wind assets Holmen II and Svindbaek in December for €36.6m.

The board has confirmed the majority of the cash proceeds – less a buffer to cover the company’s liabilities and commitments – will be used to make a first capital distribution to shareholders under the approved B share scheme.

Investors will receive a total of €34m, equivalent to 15% of NAV as of 30 September.

The B shares will be issued on 23 January and immediately redeemed.

 

Partners Group Private Equity (PEY)

Corporate action

The £958m investor in private equity direct investments confirmed it will not be topping up its buyback pot. Private equity trusts are waiting for good news after a muted 2025, with €9.2m still available under PEY’s existing €15m programme.

It adopted a new capital allocation policy in March 2024 aimed at addressing its significant share price discount. Under the policy, it committed to a 5% dividend yield and the use of ‘surplus free cashflow’ to buy back shares when they traded at a material discount.

However, it has now confirmed that as of 31 December, the free cashflow was zero, reflecting ‘balance cashflows’ and the board is therefore not allocating anymore capital to its buyback programme.

Distributions

A total of €57.6m was distributed to shareholders last year, with €51.8m coming from dividends. The remaining €5.8m was from buybacks, with 562,025 shares acquired.

The discount remains at a stubborn 22%.  

What the analysts say

Iain Scouller, analyst at Stifel, said cashflow of nil is ‘a bit disappointing given realisations totalled around €200m over 2025’.

‘In the fourth quarter there have been announced re-investments totalling €25.9m in Techem and PCI Pharma Services following the previously announced sales,’ he said.

‘We think this re-investment is a factor behind there being no positive free cashflow for the year.’